| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |